CA2085083A1 - Synthetic peptides comprising a cyclic hiv principal neutralizing determinant and a lipopeptide - Google Patents
Synthetic peptides comprising a cyclic hiv principal neutralizing determinant and a lipopeptideInfo
- Publication number
- CA2085083A1 CA2085083A1 CA002085083A CA2085083A CA2085083A1 CA 2085083 A1 CA2085083 A1 CA 2085083A1 CA 002085083 A CA002085083 A CA 002085083A CA 2085083 A CA2085083 A CA 2085083A CA 2085083 A1 CA2085083 A1 CA 2085083A1
- Authority
- CA
- Canada
- Prior art keywords
- ile
- seq
- arg
- ala phe
- hybrid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81104791A | 1991-12-18 | 1991-12-18 | |
| US811,047 | 1991-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2085083A1 true CA2085083A1 (en) | 1993-06-19 |
Family
ID=25205398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002085083A Abandoned CA2085083A1 (en) | 1991-12-18 | 1992-12-10 | Synthetic peptides comprising a cyclic hiv principal neutralizing determinant and a lipopeptide |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0547681A2 (enExample) |
| JP (1) | JPH05271276A (enExample) |
| CA (1) | CA2085083A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8808703B2 (en) * | 2010-03-23 | 2014-08-19 | Tom Yao-Hsiang Wu | Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3937412A1 (de) * | 1989-11-10 | 1991-05-16 | Hoechst Ag | Synthetische vakzine zur spezifischen induktion zytotoxischer t-lymphozyten |
| FR2670787B1 (fr) * | 1990-12-18 | 1995-06-23 | Pasteur Institut | Lipopeptides inducteurs des lymphocytes t cytotoxiques et utilisation comme vaccins. |
-
1992
- 1992-12-10 EP EP92203846A patent/EP0547681A2/en not_active Withdrawn
- 1992-12-10 CA CA002085083A patent/CA2085083A1/en not_active Abandoned
- 1992-12-15 JP JP4334730A patent/JPH05271276A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05271276A (ja) | 1993-10-19 |
| EP0547681A2 (en) | 1993-06-23 |
| EP0547681A3 (enExample) | 1994-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Defoort et al. | Macromolecular assemblage in the design of a synthetic AIDS vaccine. | |
| US5580563A (en) | Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof | |
| CA1329766C (en) | T cell epitopes of the hepatitis b virus nucleocapsid protein | |
| AU2001282706B2 (en) | HIV peptides from conserved in gag p17 and 924 and their application in E.G. vaccines | |
| Deprez et al. | Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL | |
| US5606030A (en) | Coconjugates of OMPC, HIV related peptides and anionic moieties | |
| AU650911B2 (en) | Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus | |
| US6074650A (en) | Membrane anchor/active compound conjugate, its preparation and its uses | |
| Huang et al. | Lipophilic multiple antigen peptide system for peptide immunogen and synthetic vaccine | |
| US6024964A (en) | Membrane anchor/active compound conjugate, its preparation and its uses | |
| US6015564A (en) | Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines | |
| JP3057748B2 (ja) | 細胞毒性tリンパ球の特異的誘導用合成ワクチン | |
| US5993823A (en) | Cytotoxic T lymphocyte-inducing lipopeptides and methods of use | |
| EP3790581A1 (en) | Artificial promiscuous t helper cell epitopes that facilitate targeted antibody production with limited t cell inflammatory response | |
| JPH05260963A (ja) | ペプチド−ポリサッカライド−蛋白質複合体ワクチン | |
| CA2071088A1 (en) | Conjugates of the class ii protein of the outer membrane of neisseria meningitidis and of hiv-1 related peptides, and vaccines containing same | |
| LOLEIT et al. | Conjugates of synthetic lymphocyte-activating lipopeptides with segments from HIV proteins induce protein-specific antibody formation | |
| GB2282813A (en) | Annular antigen scaffolds comprising thioether linkages | |
| CA2085083A1 (en) | Synthetic peptides comprising a cyclic hiv principal neutralizing determinant and a lipopeptide | |
| EP0467701A2 (en) | Cyclic HIV principal neutralizing determinant peptides | |
| AU759183B2 (en) | HIV-specific cytotoxic T-cell responses | |
| US7105164B1 (en) | HIV-specific cytotoxic T-cell responses | |
| IE67533B1 (en) | HIV related peptides | |
| CA2085084A1 (en) | Synthetic peptides comprising a cyclic hiv principal neutralizing determinant and a t-cell stimulatory epitope | |
| JPH05170797A (ja) | 環状hiv主要中和決定基ペプチド |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |